HealthcareUS

Arch Oncology Layoffs

January 2023

Arch Oncology announced a layoff affecting 0 employees (100% of its workforce) in January 2023. The company operates in the Healthcare sector.

Share:
People Affected

0

Percentage

100%

Announced Date

Jan 13, 2023

Company Information

Industry
Healthcare
Country
US
Region
Brisbane
Last Updated: Apr 18, 2026

About

Arch Oncology, a Roche-backed biotech startup, has laid off all its employees after discontinuing development of its anti-CD47 antibody program. The company, based in Brisbane, California, effectively ceased operations, resulting in a 100% reduction of its workforce. This decision, reported in January 2023, reflects the high-risk nature of the biotechnology industry, where startups often pivot or shut down when key drug candidates fail to progress. The move underscores the challenges in targeting the CD47 pathway in oncology.

Report an Error

If you find incorrect information, please let us know so we can correct it.

support@layoffs.nl